Rocket Pharmaceuticals Inc. (RCKT)

Business: Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases.

IPO Date: 18-Feb-2015

CEO & Director: Dr. Gaurav D. Shah M.D.

Pres & COO: Ms. Kinnari Patel M.B.A., MBA, Pharm.D., PharmD

Listing: NASDAQ: RCKT

Country: United States

Headquarters: Cranbury, NJ

Website: https://rocketpharma.com

Market cap: $790.05 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-171.87 Mln

Cash: $346.59 Mln

Total Debt: $22.43 Mln

Insider's Holding: 4.40%

Liquidity: Low

52 Week range: $7.58 - 49.66

Shares outstanding: 65,837,900

10 Years Aggregate:

• CFO: $-418.18 Mln
• EBITDA: $-546.31 Mln
• Net Profit: $-624.10 Mln